How can we tackle one of the most common diseases in the world?
Diabetes is a chronic metabolic condition characterised by high blood glucose (sugar) levels, which, if left uncontrolled, can lead to long-term damage to the heart, blood vessels, eyes, kidneys, and nerves.
How are drug developers and healthcare institutions addressing this critical disease in 2025? Andrew Barrow, Associate Director of our Life Sciences division, shares some of the latest and most significant advancements in the fight against diabetes in the newest episode of our video series ‘What’s New in Life Sciences?’.
Interested in learning more about our services or partnering with Amoria Bond? Visit our Advanced Engineering page on https://www.amoriabond.com/en/advanced-engineering/
